Article
A point-of-care assay for genotyping women prior to ovarian stimulation with recombinant or human menopausal gonadotropins in assisted reproduction.
Frontiers in endocrinology - 1 Jan 2026
Nilsson Mathilda, Hjelmér Ida, Prahl Alexandra, Nenonen Hannah, Lundberg Giwercman Yvonne
Abstract excerpt
Objective: Prior to in vitro fertilization (IVF), physicians can choose either recombinant or urine-derived follicle-stimulating hormone (FSH) for ovarian stimulation. The common polymorphism N680S (rs6166) in the follicle-stimulating hormone receptor (FSHR) has been linked to individual variability in ovarian response to FSH stimulation and IVF outcomes, including live birth rates, highlighting its potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
